{
  "subset": "contraindication",
  "disease": "Hyperammonaemia",
  "relation": "contraindication",
  "gold_drugs": [
    "hpn-100",
    "tnp-2092 capsules",
    "tnp-2092 placebo capsules"
  ],
  "seeds_initial": [
    "Acetaminophen",
    "Aspirin",
    "Ibuprofen",
    "Valproic Acid",
    "Carbamazepine",
    "Phenobarbital",
    "Rifampin",
    "Nitrofurantoin",
    "Ketorolac",
    "Cyclophosphamide",
    "Chloramphenicol",
    "Sodium Benzoate",
    "Sodium Phenylbutyrate",
    "Ammonia-Lowering Agents",
    "Glutamine",
    "L-carnitine",
    "Steroids",
    "Metformin",
    "Ciprofloxacin",
    "Moxifloxacin",
    "Gentamicin",
    "Vancomycin",
    "Atenolol",
    "Amiodarone",
    "Citalopram",
    "Sertraline",
    "Dopamine Agonists",
    "Digoxin",
    "Ketamine",
    "Morphine",
    "Fentanyl",
    "Oxcarbazepine",
    "Phenytoin",
    "Clonazepam",
    "Tramadol",
    "Dexamethasone",
    "Prednisone",
    "NSAIDs",
    "Proton Pump Inhibitors",
    "Antibiotics",
    "Furosemide",
    "Thiazide Diuretics",
    "ACE Inhibitors",
    "Angiotensin II Receptor Blockers",
    "Beta Blockers",
    "Calcium Channel Blockers",
    "Statins",
    "Antidepressants",
    "Antipsychotics",
    "Sodium Valproate",
    "Lithium",
    "Meloxicam",
    "Naproxen",
    "Salsalate",
    "Acetylsalicylic Acid",
    "Methotrexate",
    "Belladonna Alkaloids",
    "Benzodiazepines"
  ],
  "seed_history": [
    [
      "Acetaminophen",
      "Aspirin",
      "Ibuprofen",
      "Valproic Acid",
      "Carbamazepine",
      "Phenobarbital",
      "Rifampin",
      "Nitrofurantoin",
      "Ketorolac",
      "Cyclophosphamide",
      "Chloramphenicol",
      "Sodium Benzoate",
      "Sodium Phenylbutyrate",
      "Ammonia-Lowering Agents",
      "Glutamine",
      "L-carnitine",
      "Steroids",
      "Metformin",
      "Ciprofloxacin",
      "Moxifloxacin",
      "Gentamicin",
      "Vancomycin",
      "Atenolol",
      "Amiodarone",
      "Citalopram",
      "Sertraline",
      "Dopamine Agonists",
      "Digoxin",
      "Ketamine",
      "Morphine",
      "Fentanyl",
      "Oxcarbazepine",
      "Phenytoin",
      "Clonazepam",
      "Tramadol",
      "Dexamethasone",
      "Prednisone",
      "NSAIDs",
      "Proton Pump Inhibitors",
      "Antibiotics",
      "Furosemide",
      "Thiazide Diuretics",
      "ACE Inhibitors",
      "Angiotensin II Receptor Blockers",
      "Beta Blockers",
      "Calcium Channel Blockers",
      "Statins",
      "Antidepressants",
      "Antipsychotics",
      "Sodium Valproate",
      "Lithium",
      "Meloxicam",
      "Naproxen",
      "Salsalate",
      "Acetylsalicylic Acid",
      "Methotrexate",
      "Belladonna Alkaloids",
      "Benzodiazepines"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H4",
        "candidate": {
          "id": "drug_valproic_acid",
          "name": "Valproic Acid"
        },
        "score": 0.88,
        "graph_snapshot_ref": "GE_H4_round5",
        "key_assumptions": [
          "Valproic Acid 明确导致高氨血症，文献支持",
          "PK/BBB 可达性足够"
        ],
        "caveats": [
          "高氨血症的潜在临床影响需谨慎评估"
        ],
        "confidence": "high"
      },
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_acetaminophen",
          "name": "Acetaminophen"
        },
        "score": 0.84,
        "graph_snapshot_ref": "GE_H1_round5",
        "key_assumptions": [
          "Acetaminophen 与 Hyperammonaemia 有强关联，支持加重风险"
        ],
        "caveats": [
          "存在由 Skeptic 提出的高氨血症潜在反向机制"
        ],
        "confidence": "high"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_aspirin",
          "name": "Aspirin"
        },
        "score": 0.69,
        "graph_snapshot_ref": "GE_H2_round5",
        "key_assumptions": [
          "Aspirin 与高氨血症有一定关联，支持潜在风险"
        ],
        "caveats": [
          "证据仍需进一步强化"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_ibuprofen",
          "name": "Ibuprofen"
        },
        "score": 0.66,
        "graph_snapshot_ref": "GE_H3_round5",
        "key_assumptions": [
          "Ibuprofen 在机制上与高氨血症相关，但证据较弱"
        ],
        "caveats": [
          "缺乏清晰的反向机制联结"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H5",
        "candidate": {
          "id": "drug_carbamazepine",
          "name": "Carbamazepine"
        },
        "score": 0.6,
        "graph_snapshot_ref": "GE_H5_round5",
        "key_assumptions": [
          "Carbamazepine 的代谢可能影响氨排出"
        ],
        "caveats": [
          "关系不确定，需进一步探究"
        ],
        "confidence": "low"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Valproic Acid → Hyperammonaemia",
          "reason": "已知的机制与证据支持其导致高氨血症的风险"
        }
      ],
      "remaining_gaps": [
        "某些候选（如 Aspirin 和 Ibuprofen）仍需更明确证据支持其高氨血症机制"
      ]
    },
    "seed_retrospective": {
      "batches": [],
      "lessons": []
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "确保给出所有药物的潜在反向机制分析，并强化主张证据。"
      },
      {
        "role": "Skeptic",
        "patch": "在已显著的例证外，突出疑虑与可能的长期影响。"
      },
      {
        "role": "Explorer",
        "patch": "关注药物代谢信息和文献回顾的丰富性，以探求支持与反对证据。"
      }
    ],
    "heuristics": [
      {
        "when": "处方高风险药物",
        "then": "分析其与高氨血症的潜在机制，特别是代谢影响"
      },
      {
        "when": "涉及多种药物",
        "then": "识别典型的相互作用及其对临床后果的影响"
      }
    ]
  }
}